Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jan 25, 2025. (Total: 235671Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 5 (of 5 Records)

Query Trace: Hyperglycemia and AKT1[original query]
A multicenter, single-arm, open-label, phase 2 study of apitolisib (GDC-0980) for the treatment of recurrent or persistent endometrial carcinoma (MAGGIE study).
Cancer 2016 Sep .
Makker Vicky, Recio Fernando O, Ma Ling, Matulonis Ursula A, Lauchle Jennifer O, Parmar Hema, Gilbert Houston N, Ware Joseph A, Zhu Rui, Lu Shan, Huw Ling-Yuh, Wang Yulei, Koeppen Hartmut, Spoerke Jill M, Lackner Mark R, Aghajanian Carol
Effect of Capivasertib in Patients With an AKT1 E17K-Mutated Tumor: NCI-MATCH Subprotocol EAY131-Y Nonrandomized Trial.
JAMA oncology 2020 12 7 (2): 271-278.
Kalinsky Kevin, Hong Fangxin, McCourt Carolyn K, Sachdev Jasgit C, Mitchell Edith P, Zwiebel James A, Doyle L Austin, McShane Lisa M, Li Shuli, Gray Robert J, Rubinstein Larry V, Patton David, Williams Paul M, Hamilton Stanley R, Conley Barbara A, O'Dwyer Peter J, Harris Lyndsay N, Arteaga Carlos L, Chen Alice P, Flaherty Keith
Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor-Positive/HER2-Negative Advanced or Metastatic Breast Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2021 Apr .
Lim Bora, Potter David A, Salkeni Mohamad A, Silverman Paula, Haddad Tufia C, Forget Frederic, Awada Ahmad, Canon Jean-Luc, Danso Michael, Lortholary Alain, Bourgeois Hugues, Tan-Chiu Elizabeth, Vincent Sylvie, Bahamon Brittany, Galinsky Kevin J, Patel Chirag, Neuwirth Rachel, Leonard E Jane, Diamond Jennifer
Genetic Variations of AKT1 are Associated with Risk Screening for Non-Alcoholic Fatty Liver Disease.
Risk management and healthcare policy 2023 8 16 1365-1376.
Yajie Ding, Zongzhe Tang, Ru Zhang, Mengting Zhang, Qing Guan, Liuxin Zhang, Hongliang Wang, Yue Chen, Wei Zhang, Jie Wa
Capivasertib-Induced Diabetic Ketoacidosis in a Patient With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Metastatic Breast Cancer and No Prior History of Diabetes Mellitus: A Case Report.
Cureus 2024 8 16 (7): e63710.
Yoan E Rodriguez, Rishu Batra, Kunal Patel, Suzanne Martin
TOP